Cargando…
Sesamolin Protects Mice From Ovariectomized Bone Loss by Inhibiting Osteoclastogenesis and RANKL-Mediated NF-κB and MAPK Signaling Pathways
This article was submitted to Experimental Pharmacology and Drug Discovery, a section of the journal Frontiers in Pharmacology. Postmenopausal osteoporosis (PMOP), which increases the risk of fracture, is the most common bone disease in women. PMOP not only increases the risk of death but also impos...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237092/ https://www.ncbi.nlm.nih.gov/pubmed/34194327 http://dx.doi.org/10.3389/fphar.2021.664697 |
_version_ | 1783714662252019712 |
---|---|
author | Yang, Xue Liang, Jiamin Wang, Ziyi Su, Yuangang Zhan, Yunfei Wu, Zuoxing Li, Jing Li, Xuedong Chen, Runfeng Zhao, Jinmin Xu, Jiake Liu, Qian Zhou, Bo |
author_facet | Yang, Xue Liang, Jiamin Wang, Ziyi Su, Yuangang Zhan, Yunfei Wu, Zuoxing Li, Jing Li, Xuedong Chen, Runfeng Zhao, Jinmin Xu, Jiake Liu, Qian Zhou, Bo |
author_sort | Yang, Xue |
collection | PubMed |
description | This article was submitted to Experimental Pharmacology and Drug Discovery, a section of the journal Frontiers in Pharmacology. Postmenopausal osteoporosis (PMOP), which increases the risk of fracture, is the most common bone disease in women. PMOP not only increases the risk of death but also imposes a financial burden on countless families. At present, most of the drugs used to treat osteoporosis have significant side effects, so it is important to find effective anti-osteoporosis medications without major side effects. Sesamolin (Ses) is a kind of natural lignan extracted from sesame oil. Many researches have shown that Ses has anti-inflammatory, antioxidative, and anticancer effects, however it is still unknown whether it has any effect on osteoporosis. In this research, we explored the therapeutic effect of Ses in the process of osteoclast formation and bone resorption and found that Ses effectively inhibited osteoclast formation in vitro through TRAcP staining and hydroxyapatite resorption assays. Through Western blot analysis of the NF-κB pathway, MAPK pathway, c-Fos and NFATc1, it was found that Ses not only effectively inhibited the activation of NF-κB and MAPK signaling pathways induced by RANKL but also significantly reduced the protein expression of c-Fos and NFATc1. Several genes specifically expressed in osteoclasts were determined by qPCR, and Ses was also found to play a significant inhibitory role on the expression of these genes. Besides, an osteoporosis model induced in ovariectomized (OVX) mice was employed to verify that Ses could effectively reduce bone loss caused by estrogen deficiency in vivo. In conclusion, Ses showed promise as a new treatment for postmenopausal osteoporosis. |
format | Online Article Text |
id | pubmed-8237092 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-82370922021-06-29 Sesamolin Protects Mice From Ovariectomized Bone Loss by Inhibiting Osteoclastogenesis and RANKL-Mediated NF-κB and MAPK Signaling Pathways Yang, Xue Liang, Jiamin Wang, Ziyi Su, Yuangang Zhan, Yunfei Wu, Zuoxing Li, Jing Li, Xuedong Chen, Runfeng Zhao, Jinmin Xu, Jiake Liu, Qian Zhou, Bo Front Pharmacol Pharmacology This article was submitted to Experimental Pharmacology and Drug Discovery, a section of the journal Frontiers in Pharmacology. Postmenopausal osteoporosis (PMOP), which increases the risk of fracture, is the most common bone disease in women. PMOP not only increases the risk of death but also imposes a financial burden on countless families. At present, most of the drugs used to treat osteoporosis have significant side effects, so it is important to find effective anti-osteoporosis medications without major side effects. Sesamolin (Ses) is a kind of natural lignan extracted from sesame oil. Many researches have shown that Ses has anti-inflammatory, antioxidative, and anticancer effects, however it is still unknown whether it has any effect on osteoporosis. In this research, we explored the therapeutic effect of Ses in the process of osteoclast formation and bone resorption and found that Ses effectively inhibited osteoclast formation in vitro through TRAcP staining and hydroxyapatite resorption assays. Through Western blot analysis of the NF-κB pathway, MAPK pathway, c-Fos and NFATc1, it was found that Ses not only effectively inhibited the activation of NF-κB and MAPK signaling pathways induced by RANKL but also significantly reduced the protein expression of c-Fos and NFATc1. Several genes specifically expressed in osteoclasts were determined by qPCR, and Ses was also found to play a significant inhibitory role on the expression of these genes. Besides, an osteoporosis model induced in ovariectomized (OVX) mice was employed to verify that Ses could effectively reduce bone loss caused by estrogen deficiency in vivo. In conclusion, Ses showed promise as a new treatment for postmenopausal osteoporosis. Frontiers Media S.A. 2021-06-14 /pmc/articles/PMC8237092/ /pubmed/34194327 http://dx.doi.org/10.3389/fphar.2021.664697 Text en Copyright © 2021 Yang, Liang, Wang, Su, Zhan, Wu, Li, Li, Chen, Zhao, Xu, Liu and Zhou. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Yang, Xue Liang, Jiamin Wang, Ziyi Su, Yuangang Zhan, Yunfei Wu, Zuoxing Li, Jing Li, Xuedong Chen, Runfeng Zhao, Jinmin Xu, Jiake Liu, Qian Zhou, Bo Sesamolin Protects Mice From Ovariectomized Bone Loss by Inhibiting Osteoclastogenesis and RANKL-Mediated NF-κB and MAPK Signaling Pathways |
title | Sesamolin Protects Mice From Ovariectomized Bone Loss by Inhibiting Osteoclastogenesis and RANKL-Mediated NF-κB and MAPK Signaling Pathways |
title_full | Sesamolin Protects Mice From Ovariectomized Bone Loss by Inhibiting Osteoclastogenesis and RANKL-Mediated NF-κB and MAPK Signaling Pathways |
title_fullStr | Sesamolin Protects Mice From Ovariectomized Bone Loss by Inhibiting Osteoclastogenesis and RANKL-Mediated NF-κB and MAPK Signaling Pathways |
title_full_unstemmed | Sesamolin Protects Mice From Ovariectomized Bone Loss by Inhibiting Osteoclastogenesis and RANKL-Mediated NF-κB and MAPK Signaling Pathways |
title_short | Sesamolin Protects Mice From Ovariectomized Bone Loss by Inhibiting Osteoclastogenesis and RANKL-Mediated NF-κB and MAPK Signaling Pathways |
title_sort | sesamolin protects mice from ovariectomized bone loss by inhibiting osteoclastogenesis and rankl-mediated nf-κb and mapk signaling pathways |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237092/ https://www.ncbi.nlm.nih.gov/pubmed/34194327 http://dx.doi.org/10.3389/fphar.2021.664697 |
work_keys_str_mv | AT yangxue sesamolinprotectsmicefromovariectomizedbonelossbyinhibitingosteoclastogenesisandranklmediatednfkbandmapksignalingpathways AT liangjiamin sesamolinprotectsmicefromovariectomizedbonelossbyinhibitingosteoclastogenesisandranklmediatednfkbandmapksignalingpathways AT wangziyi sesamolinprotectsmicefromovariectomizedbonelossbyinhibitingosteoclastogenesisandranklmediatednfkbandmapksignalingpathways AT suyuangang sesamolinprotectsmicefromovariectomizedbonelossbyinhibitingosteoclastogenesisandranklmediatednfkbandmapksignalingpathways AT zhanyunfei sesamolinprotectsmicefromovariectomizedbonelossbyinhibitingosteoclastogenesisandranklmediatednfkbandmapksignalingpathways AT wuzuoxing sesamolinprotectsmicefromovariectomizedbonelossbyinhibitingosteoclastogenesisandranklmediatednfkbandmapksignalingpathways AT lijing sesamolinprotectsmicefromovariectomizedbonelossbyinhibitingosteoclastogenesisandranklmediatednfkbandmapksignalingpathways AT lixuedong sesamolinprotectsmicefromovariectomizedbonelossbyinhibitingosteoclastogenesisandranklmediatednfkbandmapksignalingpathways AT chenrunfeng sesamolinprotectsmicefromovariectomizedbonelossbyinhibitingosteoclastogenesisandranklmediatednfkbandmapksignalingpathways AT zhaojinmin sesamolinprotectsmicefromovariectomizedbonelossbyinhibitingosteoclastogenesisandranklmediatednfkbandmapksignalingpathways AT xujiake sesamolinprotectsmicefromovariectomizedbonelossbyinhibitingosteoclastogenesisandranklmediatednfkbandmapksignalingpathways AT liuqian sesamolinprotectsmicefromovariectomizedbonelossbyinhibitingosteoclastogenesisandranklmediatednfkbandmapksignalingpathways AT zhoubo sesamolinprotectsmicefromovariectomizedbonelossbyinhibitingosteoclastogenesisandranklmediatednfkbandmapksignalingpathways |